Navigation Links
Stemedica Achieves Major Milestone - Company Receives License to Manufacture Clinical Grade Stem Cells
Date:9/1/2009

Stemedica Cell Technologies, Inc., ("Stemedica"), a leader in adult stem cell research and manufacturing, announced today that it has been granted a license by the State of California's Food & Drug Branch to manufacture stem cells for human clinical trials. This Drug Manufacturing License recognizes Stemedica as being compliant with California law and the applicable provisions of the Code of Federal Regulations.

San Diego, CA (PRWEB) Sep 1, 2009 -- Stemedica Cell Technologies, Inc., ("Stemedica"), a leader in adult stem cell research and manufacturing, announced today that it has been granted a license by the State of California's Food & Drug Branch to manufacture stem cells for human clinical trials. This Drug Manufacturing License recognizes Stemedica as being compliant with California law and the applicable provisions of the Code of Federal Regulations.

"This is an important development for Stemedica." said Nikolai Tankovich, MD, PhD, President and Chief Medical Officer of Stemedica. "With this license we become an even stronger worldwide leader within the stem cell industry. Our stem cells and stem cell-derived factors can now be purchased by pharmaceutical and biotech companies, research institutions and medical facilities conducting approved human clinical trials. As more and more organizations get involved with stem cell research and clinical trials, including drug discovery programs, Stemedica's ability to service their needs becomes a critical asset to the organization and to the industry."

"This stamp of approval positions Stemedica as one of only a few companies in the world capable of manufacturing and delivering its own unique multiple cell products and factors. The Company also has the ability to
'/>"/>

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

0

GOOD

Page: 1 2 3

Related biology technology :

1. Stemedica Selected By World Stem Cell Summit To Present Scientific Discoveries
2. Stemedica Requests Pre-IND Meeting With FDA
3. Stemedica Signs Scientific Advisory Board Agreement with Leading Pediatric Burn & Wound Care Researcher
4. Renowned Stem Cell Researcher Files Study Results With Stemedica
5. CIRM Completes Briefing Visit to Stemedica Cell Technologies
6. Stemedica Announces the Appointment of Dr. Michael Bayer as Director, Medical Services
7. BioNeutrals Ygiene(TM) Hospital Grade Achieves a 100% Total Kill (Pass) Against the Life Threatening Clostridium Difficile (C.diff) Spores in Independent EPA Required Protocol Testing.
8. BioNeutrals Ygiene(TM) Hospital Grade Achieves World Class Independent Test Results in Killing Life Threatening Spores/Organisms
9. Environmental Tectonics Corporations BioMedical Division Achieves Foreign Manufacturer Accreditation in Japan
10. Healthy Advice Networks Achieves Strong Growth Despite Challenging Economy
11. Pepscan Achieves a Breakthrough With CLIPS Immunogen Technology: Synthetic Peptide Antigen is Able to Induce Fully Functional Antibodies Against a Formerly Intractable GPCR Target CXCR7
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Stemedica Achieves Major Milestone - Company Receives License to Manufacture Clinical Grade Stem Cells 
Stemedica Achieves Major Milestone - Company Receives License to Manufacture Clinical Grade Stem Cells
(Date:12/15/2009)... 15 The Mosaic Company (NYSE: MOS ... 2010 earnings results and financial tables on Tuesday, January ... New York Stock Exchange. Results will be available ... Company will host a conference call with presentation slides ... The call will begin at 11:00 a.m. Eastern ...
(Date:12/15/2009)... -- The Center for Business Intelligence (CBI), ... to announce the full agenda for the ... Congress . The forum will take place ... 2010. ,, Over 1,500 senior-level Finance, Accounting, ... premier event since its inception, and this ...
(Date:12/15/2009)... Thomson Reuters ... become the first drug pipeline database to fully ... This highly anticipated new content is being provided ... ,, Thomson Pharma will offer ... press releases, conferences, and other sources across all ...
(Date:12/15/2009)... of several innovative new programs to aid cash-strapped entrepreneurs ... climate. The first is aimed at entrepreneurs and ... a period of 6, 12, 18, or 24 months ... The second is aimed at more established businesses and ... 12 month period at discounted rates, and even the ...
Breaking Biology Technology:Mosaic Announces Second Quarter Fiscal Year 2010 Earnings Release and Conference Call 2CBI Announces the Agenda for Their 6th Annual Pharmaceutical/Biotech Accounting and Reporting Congress 2Thomson Reuters is First to Offer Fully Integrated Pipeline and Clinical Trials 2The Prinz Law Office Launches Innovative New Programs to Aid Cash-Strapped Entrepreneurs and Businesses 2
... Comprehensive Investor Relations and Media Outreach to ... Transdel,Pharmaceuticals, Inc. (OTC Bulletin Board: TDLP),( ... focused on developing and commercializing non-invasive, topically,administered ... a thirteen-year-old, highly recognized corporate communications,firm based ...
... Research Organization Exceeds Expectations, MEMPHIS, Tenn., ... Research,Organization exclusively focused on oncology, announced today ... projections as the company continues,to experience banner ... ability to consistently exceed client expectations, and ...
... - ("Stem Cell Sciences", "SCS", "the Company"), ... focused on the,commercialisation of stem cells and stem ... agreement with CHDI Foundation, Inc., to support the,standardisation ... lines. CHDI,is a US non-profit organisation pursuing treatments ...
Other Biology Technology:Transdel Pharmaceuticals, Inc. Retains The Investor Relations Group 2Transdel Pharmaceuticals, Inc. Retains The Investor Relations Group 3ACORN CRO Continues Growth in Strong Third Quarter 2Stem Cell Sciences Enters into Services Agreement with Huntingdon's Disease Research Group, CHDI Foundation Inc. 2Stem Cell Sciences Enters into Services Agreement with Huntingdon's Disease Research Group, CHDI Foundation Inc. 3Stem Cell Sciences Enters into Services Agreement with Huntingdon's Disease Research Group, CHDI Foundation Inc. 4
(Date:12/15/2009)... 15, 2009 Economics, environmental impacts, social dynamics, ... influence the overall success of an agroecosystem. Positive ... system, forcing individuals and social groups to continuously ... survive. , Experiential learning theory suggests that ... firsthand experiences. Such lessons are especially valuable for ...
(Date:12/15/2009)... mammoths and ancient American horses may have been ... years longer than previously thought. After plucking ancient ... team of researchers used cutting-edge techniques to uncover ... samples dated to between 7,600 and 10,500 calendar ... one population of these now-extinct mammals endured longer ...
(Date:12/15/2009)... in German . , Leipzig: Species distribution ... future distribution of mammals. This is the finding of ... European mammals. The researchers analysed data on species distribution, ... phylogenetic information of the species. Judging by the large ... mammals seem to adapt fast to changing climatic conditions. ...
Breaking Biology News(10 mins):Experiential learning teaches change and adaptation 2Late-surviving megafauna exposed by ancient DNA in frozen soil 2Late-surviving megafauna exposed by ancient DNA in frozen soil 3Late-surviving megafauna exposed by ancient DNA in frozen soil 4Species distribution models are of only limited value for predicting future mammal distributions 2FRC 3A Senate Votes to Proceed with Abortion Funding Debacle 61883 1FRC 3A Senate Votes to Proceed with Abortion Funding Debacle 61883 2River Blindness 28Onchocerciasis 29 Reduced By Nearly One Third In At Risk Populations In Six Countries 61879 1River Blindness 28Onchocerciasis 29 Reduced By Nearly One Third In At Risk Populations In Six Countries 61879 2River Blindness 28Onchocerciasis 29 Reduced By Nearly One Third In At Risk Populations In Six Countries 61879 3River Blindness 28Onchocerciasis 29 Reduced By Nearly One Third In At Risk Populations In Six Countries 61879 4KINAXO Completes Financing Round to Enhance Biomarker Development 10849 1KINAXO Completes Financing Round to Enhance Biomarker Development 10849 2KINAXO Completes Financing Round to Enhance Biomarker Development 10849 3
... have discovered epigenetic changes (i.e. chemical changes to ... sequence) in individuals with schizophrenia and bipolar disorder. ... research, and this groundbreaking data may be a ... major psychosis. , Dr. Arturas Petronis, senior scientist ...
... as a fuel alternative will worsen pollution in the Gulf ... aquatic life, according to University of British Columbia researcher Simon ... and Chris Kucharik of the University of Wisconsin quantify the ... in a waterway. Their findings will appear in the March ...
... The growth in China,s carbon dioxide (CO2) emissions is ... atmospheric greenhouse gases much more difficult, according to a ... Berkeley, and UC San Diego. , Previous estimates, including ... say the region that includes China will see a ...
Other Biology News:Epigenetic changes discovered in major psychosis 2US rush to produce corn-based ethanol will worsen 'dead zone' in Gulf of Mexico: UBC study 2New UC analysis shows alarming increase in expected growth of China's carbon dioxide emissions 2New UC analysis shows alarming increase in expected growth of China's carbon dioxide emissions 3
Fast, sensitive quantitation of Mouse IgM concentration....
Competitors to lower non-specific signal...
ExonBio Service provides one-stop recobinant protein shopping from cloning, expression and purification. Price including gene cloning....
Anti-ZFP200 Family: Zinc Finger Peptide Sequence: CGKSFNHKTNLNKHER...
Biology Products: